#small language model
Sep 2026
EGFR Mutation Subtype and Risk of Brain Metastases From Non-Small Cell Lung Cancer in the Osimertinib Era: EGFR Subtype and Brain Metastases in NSCLC.
Differences in brain metastasis development between EGFR L858R and Ex19Del mutations appeared to be mitigated among patients undergoing osimertinib compared with early-generation TKIs, representing an important systems bioengineering approach.
Ameya Patel, Victor Lee, A. H. Nassar et al.
· American Journal of Clinical... · 0 citations